Antioxidants in Neonatal Lung Disease
Overview
Pediatrics
Authors
Affiliations
Superoxide dismutase for bronchopulmonary dysplasia in preterm infants.
Albertella M, Gentyala R, Paraskevas T, Ehret D, Bruschettini M, Soll R Cochrane Database Syst Rev. 2023; 10:CD013232.
PMID: 37811631 PMC: 10561150. DOI: 10.1002/14651858.CD013232.pub2.
Thiol-Redox Regulation in Lung Development and Vascular Remodeling.
Ofman G, Tipple T Antioxid Redox Signal. 2019; 31(12):858-873.
PMID: 30648397 PMC: 6751390. DOI: 10.1089/ars.2018.7712.
Developmental regulation of antioxidant enzymes and their impact on neonatal lung disease.
Berkelhamer S, Farrow K Antioxid Redox Signal. 2013; 21(13):1837-48.
PMID: 24295375 PMC: 4203145. DOI: 10.1089/ars.2013.5515.
Prevention of bronchopulmonary dysplasia.
Laughon M, Smith P, Bose C Semin Fetal Neonatal Med. 2009; 14(6):374-82.
PMID: 19736053 PMC: 3049163. DOI: 10.1016/j.siny.2009.08.002.
Management of bronchopulmonary dysplasia in infants: guidelines for corticosteroid use.
Grier D, Halliday H Drugs. 2004; 65(1):15-29.
PMID: 15610049 DOI: 10.2165/00003495-200565010-00002.